Basic Information
Ciprofloxacin and Dexamethasone
53746-831
Regulatory Information
53746-831
ANDA216501
C73584
March 26, 2024
USA
These highlights do not include all the information needed to use CIPROFLOXACIN AND DEXAMETHASONE OTIC SUSPENSION safely and effectively. See full prescribing information for CIPROFLOXACIN AND DEXAMETHASONE OTIC SUSPENSION. CIPROFLOXACIN AND DEXAMETHASONE otic suspension Initial U.S. Approval: 2003
HUMAN PRESCRIPTION DRUG LABEL
7
Company Information
Active Ingredients
ACETIC ACID
Code: Q40Q9N063P
Class Code: IACT
BENZALKONIUM CHLORIDE
Code: F5UM2KM3W7
Class Code: IACT
BORIC ACID
Code: R57ZHV85D4
Class Code: IACT
EDETATE DISODIUM
Code: 7FLD91C86K
Class Code: IACT
HYDROCHLORIC ACID
Code: QTT17582CB
Class Code: IACT
HYDROXYETHYL CELLULOSE (100 MPA.S AT 2%)
Code: R33S7TK2EP
Class Code: IACT
SODIUM ACETATE
Code: 4550K0SC9B
Class Code: IACT
SODIUM CHLORIDE
Code: 451W47IQ8X
Class Code: IACT
TYLOXAPOL
Code: Y27PUL9H56
Class Code: IACT
SODIUM HYDROXIDE
Code: 55X04QC32I
Class Code: IACT
WATER
Code: 059QF0KO0R
Class Code: IACT
Active Moieties
CIPROFLOXACIN
Code: 5E8K9I0O4U
DEXAMETHASONE
Code: 7S5I7G3JQL